Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)

This document is a response-to-comments notice regarding development of the Percutaneous Vertebral Augmentation (PVA) LCD for osteoporotic vertebral compression fractures and does not contain clinical coverage criteria. It notes that the official notice period begins 11/26/2020 and states the final determination will become effective on 01/10/2020 (dates appear inconsistent and should be manually reviewed).

"Official notice period for the final LCD begins on 11/26/2020 and the final determination will become effective on 01/10/2020."

Sign up to see full coverage criteria, indications, and limitations.